lornoxicam and Myoma

In this prospective, randomized study, we evaluate the postoperative analgesic effect of lornoxicam after myomectomy operations.. Forty ASA I-II patients scheduled for myomectomy operation were enrolled to this study. Patients were randomly divided into two groups and epidural block was performed with 0,75 % ropivacaine. After the operation, morphine Patient Controlled Epidural Analgesia (PCEA) combined with placebo (saline 2 ml iv) and morphine PCEA combined with lornoxicam 8 mg iv were administered to patients in Group I and Group II, respectively. Pain was assessed at the 0,1st, 2nd, 4th, 6th, 8th, 12th and 24th hours postoperatively. Chi-square and student's t tests were used for statistical analysis.. VAS( Visual Analog Scale) scores were higher in Group I than Group II at 2nd, 4th, 6th and 24th hours. Total morphine consumption was 10.45+/- 4.03 in Group I and 4.25 +/- 1.74 in Group II.. Single dose iv lornoxicam is a safe and an effective treatment option of post-myomectomy pain as it produces effective analgesia, reduces morphine consumption and does not increase the side effects.

Topics: Amides; Analgesia; Analgesia, Patient-Controlled; Anesthesia, Epidural; Anesthetics, Local; Humans; Morphine; Myoma; Pain Measurement; Pain, Postoperative; Piroxicam; Placebos; Ropivacaine; Time Factors